Quanterix和Akoya修改合并协议

2025-04-29 22:26

Life sciences companies Akoya Biosciences (NASDAQ:AKYA) and Quanterix Corporation (NASDAQ:QTRX) on Tuesday announced an amendment to their previously disclosed merger agreement to add a cash element to the deal.
Under the updated terms, Quanterix plans to pay $20M in cash and issue roughly 7.8M shares of its common stock for Akoya (NASDAQ:AKYA) shareholders, indicating more than 9M fewer shares than in the original agreement.
The amendment allows Quanterix (NASDAQ:QTRX) shareholders to own about 84% of the combined entity, up from a ~70% stake previously.
Akoya (NASDAQ:AKYA) investors will claim ownership of the remaining stake after receiving 0.1461 Quanterix (NASDAQ:QTRX) shares and $0.38 per share in cash for each AKYA share they own. The merger agreement remains on track to close in Q2 2025.

More on Akoya Biosciences, Quanterix, etc.